International Business Machines Corp. (NYSE: IBM) is scheduled to release its most recent quarterly results after the markets close on Tuesday. Consensus estimates from Thomson Reuters are calling for $2.74 in earnings per share (EPS) and $19.45 billion in revenue. In the second quarter last year, IBM had $2.95 in EPS and $20.24 billion in revenue.
In a recent sharply negative report, Jefferies analyst James Kisner wrote that the company’s run at the cloud has and will be underwhelming:
Our analysis and conversations with industry contacts suggest that while IBM offers one of the more mature and broad cognitive computing platforms today, the hefty services component of many AI deployments will be a hindrance to adoption. We also believe, based on our analysis, that IBM appears outgunned in the war for talent and will likely see increasing competition over time. Finally, our analysis suggests that IBM’s AI investments aren’t likely to be NPV positive. Reiterate Underperform.
He continued that “Watson,” the cloud and AI consulting face of IBM, has likely been a mediocre contributor to the company’s fortunes, at best. Otherwise, IBM would be proud enough of its performance to break out its finances, something IBM has refused to do despite Wall Street pressure to give details.
The proof of IBM’s success, or lack thereof, will be the financial results for its second quarter. Most investors believe it will be yet another period in which revenue fell year over year. Also, IBM will provide sketchy data on Watson and related businesses.
A few other analysis weighed in on IBM ahead of the earnings report:
- Credit Suisse has an Underperform rating with a $110 price target.
- Guggenheim has a Hold rating.
- Cleveland Research has a Neutral rating.
- Stifel Nicolaus has a Buy rating with a $182 price target.
- Pacific Crest has an Equal Weight rating.
- Sanford Bernstein has a Neutral rating with a $150 price target.
So far in 2017, IBM has underperformed the broad markets and the stock is down nearly 8% year to date. Over the past 52-weeks, the stock is down about 4%.
Shares of Big Blue were last trading at $152.93, with a consensus analyst price target of $162.93 and a 52-week range of $147.79 to $182.79.